Iferanserin

Iferanserin (S-MPEC) is a selective 5-HT receptor (serotonin receptor) antagonist with an affinity for 5-HT2A receptor. Iferanserin has the potential for internal hemorrhoid disease treatment[1].

Product Specifications

CAS Number

[58754-46-4]

Product Name Alternative

S-MPEC

UNSPSC

12352005

Target

5-HT Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/iferanserin.html

Purity

99.74

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

O=C(/C=C/C1=CC=CC=C1)NC2=CC=CC=C2CC[C@H]3N(CCCC3)C

Molecular Formula

C23H28N2O

Molecular Weight

348.48

References & Citations

[1]Herold A, et al. Intra-anal Iferanserin 10 mg BID for hemorrhoid disease: a prospective, randomized, double-blind, placebo-controlled trial. Clin Ther. 2012 Feb;34 (2) :329-40.